A carregar...
Using cheminformatics to predict cross reactivity of “designer drugs” to their currently available immunoassays
BACKGROUND: A challenge for drug of abuse testing is presented by ‘designer drugs’, compounds typically discovered by modifications of existing clinical drug classes such as amphetamines and cannabinoids. Drug of abuse screening immunoassays directed at amphetamine or methamphetamine only detect a s...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4029917/ https://ncbi.nlm.nih.gov/pubmed/24851137 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1758-2946-6-22 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|